Aurobindo Pharma Share Price Hits Fresh 52-Week High at Rs 1,735: Key Reasons Behind the Rally
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Aurobindo Pharma Share Price moved to Rs 1,735 on 18 September 2026, up 3.03% from the previous close of Rs 1,683.95, and set a fresh 52-week high at the same level. The company’s market capitalisation stood at Rs 94,419.51 crore. This makes the latest Aurobindo Pharma Share Price move relevant for readers tracking Aurobindo Pharma Share Price Today, Aurobindo Pharma Stock News and broader Indian Stock Market updates. The supplied data confirms the price event and the day’s range, but it does not establish a company-specific catalyst.
The stock opened at Rs 1,687.85 and traded between Rs 1,676.40 and Rs 1,735. Turnover stood at Rs 6.24 crore. For investors scanning Aurobindo Pharma Share Price Live or Aurobindo Pharma Share Price Update pages, the key point is simple: the stock has printed a new yearly high and is now being watched alongside Aurobindo Pharma News Today and Stocks in News screens.
Aurobindo Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,735 |
| Previous Close | Rs 1,683.95 |
| Today's Move | +Rs 51.05 (+3.03%) |
| Open | Rs 1,687.85 |
| High | Rs 1,735 |
| Low | Rs 1,676.4 |
| Turnover | Rs 6.24 crore |
| Market Capitalisation | Rs 94,419.51 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) traded at Rs 1,735 versus the previous close of Rs 1,683.95, a rise of 3.03%. The stock opened at Rs 1,687.85, reached a high of Rs 1,735 and touched a low of Rs 1,676.4.
Aurobindo Pharma Share Price Today shows a session that ended at the day’s high of Rs 1,735 after opening at Rs 1,687.85. The stock added Rs 51.05 against the previous close of Rs 1,683.95, while the day’s low was Rs 1,676.40. The fresh 52-week high and the close at the top of the range make this a clear price event in Aurobindo Pharma Stock News.
The move of Rs 51.05 translates into a 3.03% rise for the day. Turnover of Rs 6.24 crore provides the value of traded business for the session. Since the current price and the 52-week high are the same, the breakout percentage versus the previous 52-week high is not applicable from the supplied data. For readers following Aurobindo Pharma Share News and Aurobindo Pharma NSE updates, the exact day’s print matters more than broad labels. The next section of Aurobindo Pharma Share Price analysis therefore turns to what the available fundamentals say about the move.
Aurobindo Pharma Ltd. (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 94,419.51 crore |
| P/E Ratio | 26.1x |
| P/B Ratio | 2.49x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.24% |
Aurobindo Pharma Ltd. (AUROPHARMA) fundamental metrics show P/E 26.1x, P/B 2.49x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.
Aurobindo Pharma Ltd. has a market capitalisation of Rs 94419.51 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.1x, P/B at 2.49x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.84x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.1x |
| Benchmark Median P/E | 32.84x |
| Benchmark Average P/E | 44.83x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 2.49x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.66% |
| Company Market Capitalisation | Rs 94,419.51 crore |
| Benchmark Median Market Cap | Rs 733.35 crore |
Aurobindo Pharma Ltd. (AUROPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 26.1x, which is below the benchmark median of 32.84x, a difference of -20.52%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aurobindo Pharma Ltd. (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.79%, a difference of -15.78%. Aurobindo Pharma Ltd. (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.66%, a difference of -6.59%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Lupin Ltd. | LUPIN | 93,611.47 | 17.3 | 4.02 | 27.11 | 28.86 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 95,591.76 | 30.36 | 2.56 | 11.69 | 13.75 |
| Mankind Pharma Ltd. | MANKIND | 92,852.54 | 46.41 | 5.63 | 12.69 | 13.24 |
| Laurus Labs Ltd. | LAURUSLABS | 1,02,983.51 | 96.68 | 18.75 | 18.31 | 18.2 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Aurobindo Pharma Ltd. (AUROPHARMA) has a P/E ratio of 26.1x compared with the displayed peer median of 32.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 12.69% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARMA) has a market capitalisation of Rs 94,419.51 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price closed at Rs 1,735, which is also the fresh 52-week high.
- The stock rose Rs 51.05, or 3.03%, from the previous close of Rs 1,683.95.
- Turnover for the session was Rs 6.24 crore.
- Market capitalisation stood at Rs 94,419.51 crore.
- P/E of 26.1 is below the same-industry median of 32.84, while ROE at 9.93% and ROCE at 12.76% stay below their benchmark medians.
About Aurobindo Pharma
Aurobindo Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data places the company within a large listed peer set and shows reported revenue, net profit, EPS, book value and dividend yield alongside market capitalisation. For Aurobindo Pharma Share Price readers, this company profile helps connect the stock event with the reported financial base used in Aurobindo Pharma Fundamental Analysis and broader Aurobindo Pharma Stock Analysis coverage.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Aurobindo Pharma Share Price on Univest for live share price, 52-week levels, fundamental ratios, shareholding pattern, market insights and company updates. Univest presents Aurobindo Pharma Share Price Today in one place alongside sector context and peer comparison tools for regular monitoring.
Conclusion: Aurobindo Pharma Share Price has reached a fresh 52-week high at Rs 1,735, with the day’s move, turnover, valuation and sector metrics all now part of the current Aurobindo Pharma Share Price story on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Aurobindo Pharma Share Price hit a fresh 52-week high?
Ans. The supplied data confirms that Aurobindo Pharma Share Price touched Rs 1,735, its fresh 52-week high, but it does not establish a company-specific catalyst. The session also ended at the day’s high.
What is Aurobindo Pharma Share Price today?
Ans. Aurobindo Pharma Share Price today stood at Rs 1,735. It rose Rs 51.05, or 3.03%, from the previous close of Rs 1,683.95 and finished at the session high. The stock moved 3.03% during the session.
What is the market capitalisation of Aurobindo Pharma?
Ans. Aurobindo Pharma’s market capitalisation is Rs 94,419.51 crore. That places the company well above the benchmark median market cap of Rs 733.35 crore within the same industry set. The company operates in the Healthcare sector.
How is Aurobindo Pharma valued against the industry benchmark?
Ans. Aurobindo Pharma’s P/E of 26.1 is below the same-industry median of 32.84 and its P/B of 2.49 is below the median of 3.1, based on the supplied benchmark data. The stock belongs to the Healthcare sector.
What do Aurobindo Pharma EPS and book value show?
Ans. Aurobindo Pharma EPS is Rs 64.52 and book value per share is Rs 676.49. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Aurobindo Pharma compare with peers on market cap?
Ans. Aurobindo Pharma’s market cap of Rs 94,419.51 crore is close to Lupin, Dr. Reddy’s Laboratories and Mankind Pharma, and below Cipla and Laurus Labs in the supplied peer set. The company operates in the Healthcare sector.
What are Aurobindo Pharma revenue and net profit figures?
Ans. Revenue for Jun 26 is Rs 91,503.5 crore and net profit is Rs 10,325.6 crore. The prior year comparable figures were Rs 78,681.4 crore in revenue and Rs 8,247.5 crore in net profit.
What do ROE and ROCE show for Aurobindo Pharma?
Ans. Aurobindo Pharma’s ROE is 9.93% and ROCE is 12.76%. Both are below the supplied industry benchmark medians, which gives useful context for Aurobindo Pharma Share Price analysis. ROE stands at 9.93%.
Should investors track Aurobindo Pharma Share Price on Univest?
Ans. Univest tracks Aurobindo Pharma Share Price, market cap, 52-week levels, valuation ratios and peer comparisons in one place. That makes it useful for monitoring Aurobindo Pharma Stock News and company updates.
